SLCO1B1 c.1288_1289delinsAC ;(p.C430T)

Variant ID: 12-21355577-TG-AC

NM_006446.4(SLCO1B1):c.1288_1289delinsAC;(p.C430T)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Role of Drug-Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity.

Drug Safety
Jessurun, Naomi T NT; Drent, Marjolein M; Wijnen, Petal A PA; Harmsze, Ankie M AM; van Puijenbroek, Eugène P EP; Bekers, Otto O; Bast, Aalt A
Publication Date: 2021-11

Variant appearance in text: SLCO1B1: C430T
PubMed Link: 34606062
Variant Present in the following documents:
  • Main text
  • 40264_2021_Article_1105.pdf
View BVdb publication page



Role of Drug-Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity.

Drug Safety
Jessurun, Naomi T NT; Drent, Marjolein M; Wijnen, Petal A PA; Harmsze, Ankie M AM; van Puijenbroek, Eugène P EP; Bekers, Otto O; Bast, Aalt A
Publication Date: 2021-11

Variant appearance in text: SLCO1B1: C430T
PubMed Link: 34606062
Variant Present in the following documents:
  • Main text
  • 40264_2021_Article_1105.pdf
View BVdb publication page



Drug-Drug Interactions and Pharmacogenomic Evaluation in Colorectal Cancer Patients: The New Drug-PIN® System Comprehensive Approach.

Pharmaceuticals (Basel, Switzerland)
Roberto, Michela M; Rossi, Alessandro A; Panebianco, Martina M; Pomes, Leda Marina LM; Arrivi, Giulia G; Ierinò, Debora D; Simmaco, Maurizio M; Marchetti, Paolo P; Mazzuca, Federica F
Publication Date: 2021-01-15

Variant appearance in text: SLCO1B1: C430T
PubMed Link: 33467633
Variant Present in the following documents:
  • pharmaceuticals-14-00067-s001.pdf
View BVdb publication page



The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.

Cardiovascular Drugs And Therapy
Flaten, Hania K HK; Monte, Andrew A AA
Publication Date: 2017-08

Variant appearance in text: SLCO1B1: C430T
PubMed Link: 28741243
Variant Present in the following documents:
  • Main text
View BVdb publication page



Comparison of CYP2C9, CYP2C19, CYP2D6, ABCB1, and SLCO1B1 gene-polymorphism frequency in Russian and Nanai populations.

Pharmacogenomics And Personalized Medicine
Sychev, Dmitrij Alekseevitch DA; Shuev, Grigorij Nikolaevich GN; Suleymanov, Salavat Shejhovich SS; Ryzhikova, Kristina Anatol'evna KA; Mirzaev, Karin Badavievich KB; Grishina, Elena Anatol'evna EA; Snalina, Natalia Evgenievna NE; Sozaeva, Zhannet Alimovna ZA; Grabuzdov, Anton Mikhailovich AM; Matsneva, Irina Andreevna IA
Publication Date: 2017

Variant appearance in text: SLCO1B1: C430T
PubMed Link: 28435307
Variant Present in the following documents:
  • Main text
View BVdb publication page



Characterization of clinical and genetic risk factors associated with dyslipidemia after kidney transplantation.

Disease Markers
Numakura, Kazuyuki K; Kagaya, Hideaki H; Yamamoto, Ryohei R; Komine, Naoki N; Saito, Mitsuru M; Hiroshi, Tsuruta T; Akihama, Susumu S; Inoue, Takamitsu T; Narita, Shintaro S; Tsuchiya, Norihiko N; Habuchi, Tomonori T; Niioka, Takenori T; Miura, Masatomo M; Satoh, Shigeru S
Publication Date: 2015

Variant appearance in text: OATP1B1: C430T
PubMed Link: 25944971
Variant Present in the following documents:
  • Main text
View BVdb publication page